Gyre Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 531,680 | $6.43 M | 3.36% | 0.62% |
| VANGUARD GROUP INC | 02/11/2025 | 322,464 | $3.90 M | -5.21% | 0.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 304,098 | $3.68 M | 0.15% | 0.36% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 114,566 | $1.39 M | 0.81% | 0.13% |
| NORTHERN TRUST CORP | 02/14/2025 | 103,382 | $1.25 M | 9.10% | 0.12% |
| 02/06/2025 | 101,239 | $1.22 M | 100.00% | 0.12% | |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 26,386 | $319,271 | 40.36% | 0.03% |
| BELVEDERE TRADING LLC | 01/31/2025 | 20,000 | $15,600 | 0.00% | 0.02% |
| MORGAN STANLEY | 02/14/2025 | 15,241 | $184,416 | -16.36% | 0.02% |
| BARCLAYS PLC | 02/13/2025 | 10,543 | $128,000 | 13.51% | 0.01% |
| RHUMBLINE ADVISERS | 01/30/2025 | 10,432 | $126,222 | 0.08% | 0.01% |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 02/11/2025 | 8,873 | $107,363 | -66.69% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 6,937 | $83,938 | 40.40% | 0.01% |
| CITIGROUP INC | 02/12/2025 | 5,399 | $65,328 | 6.36% | 0.01% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 4,013 | $48,557 | 3.94% | 0.00% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 3,468 | $41,963 | -7.02% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 2,700 | $33,000 | 0.00% | 0.00% |
| BELVEDERE TRADING LLC | 01/31/2025 | 2,461 | $29,778 | -2.15% | 0.00% |
| FMR LLC | 02/13/2025 | 1,256 | $15,198 | -66.44% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 852 | $10,309 | -0.70% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 683 | $8,264 | 0.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 603 | $7,290 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 533 | $6,449 | 0.00% | 0.00% |
| AMALGAMATED BANK | 02/04/2025 | 241 | $3,000 | 0.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 216 | $2,614 | 928.57% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 84 | $1,016 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 75 | $908 | 100.00% | 0.00% |
| GAMMA INVESTING LLC | 01/03/2025 | 12 | $145 | 100.00% | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gyre Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Gyre Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 531,680
VANGUARD GROUP INC: 322,464
GEODE CAPITAL MANAGEMENT, LLC: 304,098
CHARLES SCHWAB INVESTMENT MANAGEMENT INC: 114,566
NORTHERN TRUST CORP: 103,382
GOLDMAN SACHS GROUP INC: 26,386
1.94% of Gyre Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.97 M shares in the last 24 months. This purchase volume represents approximately $17.93 M in transactions.